Marsh & McLennan CEO sells 16,656 shares of stock
MRSH’s President and CEO exercised options for 16,656 shares and sold the same number under a pre-arranged Rule 10b5-1 trading plan.
Rhea-AI Filing Summary
MARSH & MCLENNAN COMPANIES, INC. (MRSH) reported that President and CEO John Q. Doyle exercised stock options for 16,656 shares of common stock on September 2, 2026 at an exercise price of $73.195 per share, converting previously granted options into shares.
On the same date, he sold 16,656 shares of common stock at a reported price of $188.51 per share. The filing states that these transactions were effected pursuant to a previously adopted Rule 10b5-1 trading plan, indicating they were pre-arranged rather than opportunistic.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 16,656 shares ($1.92M approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Doyle John Q
Role
President and CEO
Sold
16,656 shs ($3.14M)
Approx. gross sale proceeds
$3.14M
Approx. exercise cost
$1.22M
Approx. pre-tax spread
$1.92M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (Right to Buy) F1, F2 | 16,656 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 16,656 | $73.195 | $1.22M |
| Sale | Common Stock F1 | 16,656 | $188.51 | $3.14M |
Holdings After Transaction:
Stock Options (Right to Buy) — 16,656 contracts (Direct);
Common Stock — 116,811.0205 shares (Direct)
Footnotes (2)
- F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- F2. These options were granted on February 22, 2017 and vested in four equal annual installments on February 22nd of 2018, 2019, 2020 and 2021.
Key Figures
Options exercised: 16,656 shares
Option exercise price: $73.195 per share
Shares sold: 16,656 shares
+3 more
6 metrics
Options exercised
16,656 shares
Stock options exercised into common stock on September 2, 2026
Option exercise price
$73.195 per share
Exercise price for options converting into 16,656 shares of common stock
Shares sold
16,656 shares
Common stock sold on September 2, 2026 following the option exercise
Sale price
$188.51 per share
Reported price for the sale of 16,656 shares of common stock
Options grant date
February 22, 2017
Grant date of the options that were exercised
Option expiration date
February 21, 2027
Expiration date of the stock options that were exercised
Key Terms
Rule 10b5-1 trading plan, stock options, derivative security
3 terms
Rule 10b5-1 trading plan regulatory
"This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
stock options financial
"These options were granted on February 22, 2017 and vested in four equal annual installments"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
What insider transactions did MRSH report for President and CEO John Q. Doyle?
MARSH & MCLENNAN COMPANIES, INC. reported that John Q. Doyle exercised stock options for 16,656 shares of common stock at $73.195 per share on September 2, 2026 and sold 16,656 shares at $188.51 per share the same day.
Was John Q. Doyle’s MRSH stock sale under a Rule 10b5-1 trading plan?
Yes. A footnote states that the reported transactions were effected pursuant to a Rule 10b5-1 trading plan previously adopted by John Q. Doyle, indicating the exercise and sale were pre-arranged under that plan.
At what price did John Q. Doyle sell MRSH common stock on September 2, 2026?
The filing reports that John Q. Doyle sold 16,656 shares of MARSH & MCLENNAN COMPANIES, INC. common stock at a price of $188.51 per share on September 2, 2026.
What options did John Q. Doyle exercise in the latest MRSH Form 4?
He exercised stock options covering 16,656 shares of common stock with an exercise price of $73.195 per share. A footnote explains these options were granted on February 22, 2017 and vested in four equal annual installments from 2018 through 2021.
AI-generated analysis. How Rhea-AI works. Not financial advice.
